Clinical Trial Update: A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis [Phase 3]

View source ↗

Summary

A Phase 3 pilot study evaluated risperidone long-acting injectable for patients with recent-onset psychosis associated with schizophrenia. The trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED